These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 33816349)

  • 1. Chitosan-Based Nanoparticles Against Viral Infections.
    Boroumand H; Badie F; Mazaheri S; Seyedi ZS; Nahand JS; Nejati M; Baghi HB; Abbasi-Kolli M; Badehnoosh B; Ghandali M; Hamblin MR; Mirzaei H
    Front Cell Infect Microbiol; 2021; 11():643953. PubMed ID: 33816349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting.
    Garg U; Chauhan S; Nagaich U; Jain N
    Adv Pharm Bull; 2019 Jun; 9(2):195-204. PubMed ID: 31380245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.
    Karayianni M; Sentoukas T; Skandalis A; Pippa N; Pispas S
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
    Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based antiviral therapeutics.
    Chakravarty M; Vora A
    Drug Deliv Transl Res; 2021 Jun; 11(3):748-787. PubMed ID: 32748035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoencapsulation of inactivated-viral vaccine using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in olive flounder (Paralichthys olivaceus) against viral haemorrhagic septicaemia virus (VHSV) infection.
    Kole S; Qadiri SSN; Shin SM; Kim WS; Lee J; Jung SJ
    Fish Shellfish Immunol; 2019 Aug; 91():136-147. PubMed ID: 31096061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
    Sharma M; Sharma R; Jain DK; Saraf A
    Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
    Islam N; Ferro V
    Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D; Jaganathan KS
    Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
    Lin Y; Sun B; Jin Z; Zhao K
    ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan magnetic nanoparticles for drug delivery systems.
    Assa F; Jafarizadeh-Malmiri H; Ajamein H; Vaghari H; Anarjan N; Ahmadi O; Berenjian A
    Crit Rev Biotechnol; 2017 Jun; 37(4):492-509. PubMed ID: 27248312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan Nanoparticle Based Mucosal Vaccines Delivered Against Infectious Diseases of Poultry and Pigs.
    Renu S; Renukaradhya GJ
    Front Bioeng Biotechnol; 2020; 8():558349. PubMed ID: 33282847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
    Hard SAAA; Shivakumar HN; Redhwan MAM
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan: a propitious biopolymer for drug delivery.
    Duttagupta DS; Jadhav VM; Kadam VJ
    Curr Drug Deliv; 2015; 12(4):369-81. PubMed ID: 25761010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.
    Ahmed TA; Aljaeid BM
    Drug Des Devel Ther; 2016; 10():483-507. PubMed ID: 26869768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoparticles: a promising system in novel drug delivery.
    Nagpal K; Singh SK; Mishra DN
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1423-30. PubMed ID: 21048331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.